Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils
Authors
- J. Bieschke
- M. Herbst
- T. Wiglenda
- R.P. Friedrich
- A. Boeddrich
- F. Schiele
- D. Kleckers
- J.M. Lopez Del Amo
- B.A. Gruening
- Q. Wang
- M.R. Schmidt
- R. Lurz
- R. Anwyl
- S. Schnoegl
- M. Faendrich
- R.F. Frank
- B. Reif
- S. Guenther
- D.M. Walsh
- E.E. Wanker
Journal
- Nature Chemical Biology
Citation
- Nat Chem Biol 8 (1): 93-101
Abstract
Several lines of evidence indicate that prefibrillar assemblies of amyloid-{beta} (A{beta}) polypeptides, such as soluble oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease. These findings suggest that reducing the prevalence of transient intermediates by small molecule-mediated stimulation of amyloid polymerization might decrease toxicity. Here we demonstrate the acceleration of A{beta} fibrillogenesis through the action of the orcein-related small molecule O4, which directly binds to hydrophobic amino acid residues in A{beta} peptides and stabilizes the self-assembly of seeding-competent, {beta}-sheet-rich protofibrils and fibrils. Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concentration of small, toxic A{beta} oligomers in complex, heterogeneous aggregation reactions. In addition, O4 treatment suppresses inhibition of long-term potentiation by A{beta} oligomers in hippocampal brain slices. These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.